Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riitta Lassila

Showing results (31-40 of 162) with videos related to

Pageof 17
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 26, 2025
Assessing the diagnostic value of oncological biomarkers for identifying primary malignancies in skeletal metastatic diseaseSanna Matilainen, Hanna Liikanen, Riitta Lassila, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 28, 2026
Therapeutic Strategies Combining Antiplatelet With Anticoagulant Actions: Heparin Proteoglycan Mimetic APAC as a ModelAxelle Y Kern, Annukka Jouppila, Hanna Pitkänen, et al.
ESMO Open|August 11, 2018
Real-world features associated with cancer-related venous thromboembolic eventsMaija Helena Peippo, Samu Kurki, Riitta Lassila, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 26, 2012
Alterations of sympathetic nervous system, coagulation and platelet function in gestational diabetesMaritta Pöyhönen-Alho, Lotta Joutsi-Korhonen, Riitta Lassila, et al.
Thrombosis Research|April 19, 2025
Antiplatelet-anticoagulant, APAC, a mimic of endogenous heparin, is an antithrombotic with von Willebrand factor-mediated characteristicsAnnukka Jouppila, Ilja Nevola, Marja Lemponen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 16, 2013
Thrombophilia and arteriovenous fistula survival in ESRDBirgitta Salmela, Jari Hartman, Seija Peltonen, et al.
Thrombosis and Haemostasis|February 19, 2008
Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assaysPeter Raivio, Anne Kuitunen, Jari Petäjä, et al.
European Journal of Haematology|January 27, 2016
Haemophilia in a real-world setting: the value of clinical experience in data collectionGerry Dolan, Alfonso Iorio, Vuokko Jokela, et al.
Thrombosis Journal|November 24, 2022
Preoperative coagulation biomarkers associate with survival and pulmonary embolism after surgical treatment of non-spinal skeletal metastasesSanna Matilainen, Gilber Kask, Jyrki Nieminen, et al.
Journal of Thrombosis and Haemostasis : JTH|November 21, 2024
Use of antithrombotic therapy in patients with hemophilia: a selected synopsis of the European Hematology Association - International Society on Thrombosis and Haemostasis - European Association for Hemophilia and Allied Disorders - European Stroke Organization Clinical Practice Guidance documentMiguel Escobar, Riitta Lassila, Carine Bekdache, et al.
Pageof 17

Showing results (31-40 of 162) with videos related to

Sort By:
Pageof 17
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 26, 2025
Assessing the diagnostic value of oncological biomarkers for identifying primary malignancies in skeletal metastatic diseaseSanna Matilainen, Hanna Liikanen, Riitta Lassila, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 28, 2026
Therapeutic Strategies Combining Antiplatelet With Anticoagulant Actions: Heparin Proteoglycan Mimetic APAC as a ModelAxelle Y Kern, Annukka Jouppila, Hanna Pitkänen, et al.
ESMO Open|August 11, 2018
Real-world features associated with cancer-related venous thromboembolic eventsMaija Helena Peippo, Samu Kurki, Riitta Lassila, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 26, 2012
Alterations of sympathetic nervous system, coagulation and platelet function in gestational diabetesMaritta Pöyhönen-Alho, Lotta Joutsi-Korhonen, Riitta Lassila, et al.
Thrombosis Research|April 19, 2025
Antiplatelet-anticoagulant, APAC, a mimic of endogenous heparin, is an antithrombotic with von Willebrand factor-mediated characteristicsAnnukka Jouppila, Ilja Nevola, Marja Lemponen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 16, 2013
Thrombophilia and arteriovenous fistula survival in ESRDBirgitta Salmela, Jari Hartman, Seija Peltonen, et al.
Thrombosis and Haemostasis|February 19, 2008
Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assaysPeter Raivio, Anne Kuitunen, Jari Petäjä, et al.
European Journal of Haematology|January 27, 2016
Haemophilia in a real-world setting: the value of clinical experience in data collectionGerry Dolan, Alfonso Iorio, Vuokko Jokela, et al.
Thrombosis Journal|November 24, 2022
Preoperative coagulation biomarkers associate with survival and pulmonary embolism after surgical treatment of non-spinal skeletal metastasesSanna Matilainen, Gilber Kask, Jyrki Nieminen, et al.
Journal of Thrombosis and Haemostasis : JTH|November 21, 2024
Use of antithrombotic therapy in patients with hemophilia: a selected synopsis of the European Hematology Association - International Society on Thrombosis and Haemostasis - European Association for Hemophilia and Allied Disorders - European Stroke Organization Clinical Practice Guidance documentMiguel Escobar, Riitta Lassila, Carine Bekdache, et al.
Pageof 17